G9931 HCPCS Level II Code: Documentation of cha2ds2-vasc risk score of 0 or 1 for men; or 0, 1, or 2 for women

Contextual Map

Every relationship of G9931 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (40)

• G9911 — Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant systemic therapy[Sibling]— CMS HCPCS Level II code set
• G9912 — Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy[Sibling]— CMS HCPCS Level II code set
• G9913 — Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified[Sibling]— CMS HCPCS Level II code set
• G9914 — Patient initiated an anti-tnf agent[Sibling]— CMS HCPCS Level II code set
• G9915 — No record of hbv results documented[Sibling]— CMS HCPCS Level II code set
• G9916 — Functional status performed once in the last 12 months[Sibling]— CMS HCPCS Level II code set
• G9917 — Documentation of advanced stage dementia and caregiver knowledge is limited[Sibling]— CMS HCPCS Level II code set
• G9918 — Functional status not performed, reason not otherwise specified[Sibling]— CMS HCPCS Level II code set
• and 32 more

Change history

• January 1, 2018 — Added to the code set [Change history]— CMS release files (code change ledger)

Sources for this page

Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.

Code, descriptors, coverage and pricing attributes Official source data

CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update Release, file and checksum · Publisher’s page

Change history and date-of-service validity Official source data

CMS HCPCS quarterly update files, ingested into the change ledger Release, file and checksum · Publisher’s page

Comparisons, relationships and the contextual map MedCoder structured relationship

Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears

Summary and FAQ answers MedCoder explanation

Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.

Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates

Nearest Codes in This Family

Official HCPCS Level II classifications closest to G9931 in its code family, with their registry titles.

• G9926 — Safety concerns screening positive screen is without provision of mitigation recommendations, including but not limited to referral to other resources
• G9927 — Documentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment
• G9928 — Fda-approved anticoagulant not prescribed, reason not given
• G9929 — Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)
• G9930 — Patients who are receiving comfort care only
• G9932 — Documentation of patient reason(s) for not having records of negative or managed positive tb screen (e.g., patient does not return for mantoux (ppd) skin test evaluation)
• G9933 — Adenoma(s) or colorectal cancer detected during screening colonoscopy
• G9934 — Documentation that neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma
• G9935 — Adenoma(s) or colorectal cancer not detected during screening colonoscopy
• G9936 — Surveillance colonoscopy - personal history of colonic polyps, colon cancer, or other malignant neoplasm of rectum, rectosigmoid junction, and anus